对《从片剂过敏免疫治疗后对治疗结果的有限影响推断Der p 23的临床相关性》的回复 - Suppr

Suppr

超能文献

Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy".

作者信息

Stranzl Thomas, Ipsen Henrik, Christensen Lars Harder, Eiwegger Thomas, Johansen Niels, Lund Kaare, Andersen Peter Sejr

机构信息

ALK-Abelló A/S, Hørsholm, Denmark.

HICon, Capital Region, Denmark.

出版信息

Allergy. 2021 Apr;76(4):1300-1301. doi: 10.1111/all.14636.

DOI:10.1111/all.14636

PMID:33840114

Abstract

摘要

相似文献

Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy".

Allergy. 2021 Apr;76(4):1300-1301. doi: 10.1111/all.14636.

Inferring clinical relevance of Der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy.

Allergy. 2021 Apr;76(4):1298-1299. doi: 10.1111/all.14433.

Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study.

Allergy. 2021 Apr;76(4):1235-1238. doi: 10.1111/all.14200. Epub 2020 Feb 19.

Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions.

Ann Allergy Asthma Immunol. 2016 Sep;117(3):298-303. doi: 10.1016/j.anai.2016.07.004.

Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.

Int Arch Allergy Immunol. 2017;174(1):26-34. doi: 10.1159/000479693. Epub 2017 Sep 27.

The Effective Allergenic Reactivity of House Dust Mite Sublingual Immunotherapy Tablets Is Determined by Tablet Formulation.

Biol Pharm Bull. 2019;42(6):1030-1033. doi: 10.1248/bpb.b18-00857.

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.

J Allergy Clin Immunol. 2016 Oct;138(4):1081-1088.e4. doi: 10.1016/j.jaci.2016.04.061. Epub 2016 Jul 15.

The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.

Allergol Int. 2018 Jul;67(3):301-308. doi: 10.1016/j.alit.2018.03.008. Epub 2018 May 16.

Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany.

J Allergy Clin Immunol. 2018 May;141(5):1898-1901.e5. doi: 10.1016/j.jaci.2017.12.999. Epub 2018 Feb 2.

A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.

Postgrad Med. 2017 Aug;129(6):590-597. doi: 10.1080/00325481.2017.1302306. Epub 2017 Mar 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy".

作者信息

Stranzl Thomas, Ipsen Henrik, Christensen Lars Harder, Eiwegger Thomas, Johansen Niels, Lund Kaare, Andersen Peter Sejr

机构信息

ALK-Abelló A/S, Hørsholm, Denmark.

HICon, Capital Region, Denmark.

出版信息

Allergy. 2021 Apr;76(4):1300-1301. doi: 10.1111/all.14636.

DOI:10.1111/all.14636

PMID:33840114

Abstract

摘要

相似文献

Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy".

Allergy. 2021 Apr;76(4):1300-1301. doi: 10.1111/all.14636.

Inferring clinical relevance of Der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy.

Allergy. 2021 Apr;76(4):1298-1299. doi: 10.1111/all.14433.

Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study.

Allergy. 2021 Apr;76(4):1235-1238. doi: 10.1111/all.14200. Epub 2020 Feb 19.

Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions.

Ann Allergy Asthma Immunol. 2016 Sep;117(3):298-303. doi: 10.1016/j.anai.2016.07.004.

Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.

Int Arch Allergy Immunol. 2017;174(1):26-34. doi: 10.1159/000479693. Epub 2017 Sep 27.

The Effective Allergenic Reactivity of House Dust Mite Sublingual Immunotherapy Tablets Is Determined by Tablet Formulation.

Biol Pharm Bull. 2019;42(6):1030-1033. doi: 10.1248/bpb.b18-00857.

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.

J Allergy Clin Immunol. 2016 Oct;138(4):1081-1088.e4. doi: 10.1016/j.jaci.2016.04.061. Epub 2016 Jul 15.

The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.

Allergol Int. 2018 Jul;67(3):301-308. doi: 10.1016/j.alit.2018.03.008. Epub 2018 May 16.

Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany.

J Allergy Clin Immunol. 2018 May;141(5):1898-1901.e5. doi: 10.1016/j.jaci.2017.12.999. Epub 2018 Feb 2.

A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.

Postgrad Med. 2017 Aug;129(6):590-597. doi: 10.1080/00325481.2017.1302306. Epub 2017 Mar 22.